Product image of Olimel N12 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin) supplied by GNH India

Olimel N12

Active Ingredient:
Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin
Origin:
EU

Olimel N12 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N12, is a mixture of essential and non-essential amino acids presented as a powder for oral use. It supports metabolic processes and may be used in clinical nutrition contexts.

GNH India supplies Olimel N12 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Manufacturer / TM Owner

Baxter Czech Spol. S R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Olimel N12 is a nutritionally focused product that acts on protein synthesis pathways.

  • Metabolic support in malnutrition: Helps restore amino acid balance in patients with protein‑energy malnutrition.
  • Post‑operative recovery: Contributes to tissue repair and nitrogen balance during convalescence.
  • Critical care nutrition: Provides essential amino acids for patients receiving enteral or parenteral nutrition.
  • Chronic disease management: Supports muscle maintenance in long‑term illness.
  • Pediatric nutrition: Assists in growth support for children with increased nutritional needs.

How It Works

  • Olimel N12 supplies a blend of amino acids that are directly incorporated into the body's protein synthesis machinery. The individual amino acids act as substrates for ribosomal translation, replenish nitrogen pools, and stimulate anabolic signaling pathways such as mTOR, thereby facilitating tissue repair and metabolic homeostasis.

Side Effects

Adverse reactions to amino acid mixtures are generally mild and related to the route of administration.

Common Side Effects

  • Nausea: Mild stomach upset reported in some patients.
  • Diarrhea: Loose stools may occur, especially with rapid infusion.
  • Metallic taste: Transient taste alteration during oral administration.
  • Injection site discomfort: Local irritation when given intravenously.

Serious or Rare Side Effects

  • Hyperammonemia: Elevated ammonia levels in susceptible individuals.
  • Allergic reaction: Rash, itching, or anaphylaxis in rare cases.
  • Electrolyte imbalance: Disturbances due to rapid amino acid shifts.
  • Metabolic acidosis: Rare acid‑base disturbance linked to high amino acid load.

Precautions & Warnings

When using Olimel N12, consider the following safety measures:

  • Renal function assessment: Evaluate kidney performance before initiating therapy.
  • Hepatic monitoring: Check liver enzymes in patients with liver disease.
  • Fluid balance: Adjust concomitant fluids to avoid overload.
  • Electrolyte surveillance: Monitor serum electrolytes during high‑dose regimens.
  • Metabolic monitoring: Observe for signs of nitrogen overload.
  • Store at below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Olimel N12 may interact with other agents that affect nitrogen metabolism or electrolyte balance.

Major Interactions (Avoid)

  • High‑dose nitrogen scavengers: May exacerbate ammonia accumulation.
  • Certain diuretics: Can worsen electrolyte disturbances when combined.

Moderate Interactions (Monitor Closely)

  • Parenteral nutrition solutions: Requires compatibility testing before mixing.\n- Anticonvulsants that alter amino acid levels: May need dose adjustments.
  • Insulin therapy: Amino acids can stimulate insulin release, affecting glycemic control.
  • Renal replacement therapies: May remove administered amino acids, altering efficacy.

Frequently Asked Questions

Olimel N12 is a pharmaceutical‑grade amino acid mixture used primarily in clinical nutrition to provide essential and non‑essential amino acids for patients who require metabolic support, such as those with malnutrition, post‑surgical recovery, or critical‑care needs.

The blend delivers individual amino acids that serve as direct substrates for protein synthesis and replenish nitrogen stores. By supplying these building blocks, it activates anabolic pathways like mTOR, helping to restore tissue integrity and support overall metabolic balance.

Dosing is individualized; the prescribing clinician determines the amount based on the patient’s nutritional status, weight, renal and hepatic function, and the intended route of administration.

Safety data are limited. The product should only be used in pregnancy or lactation if the potential benefit justifies any potential risk, and this decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Olimel N12 provides a comprehensive blend of ten amino acids in a single formulation, which can simplify compounding compared with products that require mixing multiple single‑amino‑acid solutions. Clinical choice depends on specific patient needs, compatibility with existing nutrition regimens, and local formulary preferences.

Store the powder below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Ensure the container is tightly sealed to maintain stability until the point of reconstitution or administration.

The product is supplied as a sterile powder that is reconstituted with a suitable diluent and administered orally, via nasogastric tube, or intravenously according to the prescribing clinician’s instructions and the patient’s route of nutrition.

Serious risks include hyperammonemia, severe allergic reactions such as anaphylaxis, electrolyte disturbances, and metabolic acidosis. Patients should be monitored closely for these events, especially when high doses are used or when underlying organ dysfunction exists.

Individuals with known hypersensitivity to any of the amino acids in the formulation, patients with uncontrolled hyperammonemia, and those with severe renal or hepatic impairment where amino acid load cannot be safely managed should avoid using Olimel N12.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.